CoChat

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques

Open access
Yadav, Pragya D., Ella, Raches, Kumar, Sanjay, Patil, Dilip R., Mohandas, Sreelekshmy, Shete, Anita M., Vadrevu, Krishna M., Bhati, Gaurav, Sapkal, Gajanan, Kaushal, Himanshu, Patil, Savita, Jain, Rajlaxmi, Deshpande, Gururaj, Gupta, Nivedita, Agarwal, Kshitij, Gokhale, Mangesh, Mathapati, Basavaraj, Metkari, Siddhanath, Mote, Chandrashekhar, Nyayanit, Dimpal, Patil, Deepak Y., Sai Prasad, B. S., Suryawanshi, Annasaheb, Kadam, Manoj, Kumar, Abhimanyu, Daigude, Sachin, Gopale, Sanjay, Majumdar, Triparna, Mali, Deepak, Sarkale, Prasad, Baradkar, Shreekant, Gawande, Pranita, Joshi, Yash, Fulari, Sidharam, Dighe, Hitesh, Sharma, Sharda, Gunjikar, Rashmi, Kumar, Abhinendra, Kalele, Kaumudi, Srinivas, Vellimedu K., Gangakhedkar, Raman R., Ella, Krishna M., Abraham, Priya, Panda, Samiran, Bhargava, Balram · 2021 · Nature Communications
Cited by 107

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The COVID-19 pandemic is a global health crisis that poses a great challenge to the public health system of affected countries. Safe and effective vaccines are needed to overcome this crisis. Here, we develop and assess the protective efficacy and immunogenicity of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Twenty macaques were divided into four groups of five animals each. One group was administered a placebo, while three groups were immunized with three different vaccine candidates of BBV152 at 0 and 14 days. All the macaques were challenged with SARS-CoV-2 fourteen days after the second dose. The protective response was observed with increasing SARS-CoV-2 specific IgG and neutralizing antibody titers from 3 rd -week post-immunization. Viral clearance was observed from bronchoalveolar lavage fluid, nasal swab, throat swab and lung tissues at 7 days post-infection in the vaccinated groups. No evidence of pneumonia was observed by histopathological examination in vaccinated groups, unlike the placebo group which exhibited interstitial pneumonia and localization of viral antigen in the alveolar epithelium and macrophages by immunohistochemistry. This vaccine candidate BBV152 has completed Phase I/II (NCT04471519) clinical trials in India and is presently in phase III, data of this study substantiates the immunogenicity and protective efficacy of the vaccine candidates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-21639-w

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 107

Metadata

Authors
Yadav, P. D., Ella, R., Kumar, S., Patil, D. R., Mohandas, S., Shete, A. M., Vadrevu, K. M., Bhati, G., Sapkal, G., Kaushal, H., Patil, S., Jain, R., Deshpande, G., Gupta, N., Agarwal, K., Gokhale, M., Mathapati, B., Metkari, S., Mote, C., Nyayanit, D., Patil, D. Y., Sai Prasad, B. S., Suryawanshi, A., Kadam, M., Kumar, A., Daigude, S., Gopale, S., Majumdar, T., Mali, D., Sarkale, P., Baradkar, S., Gawande, P., Joshi, Y., Fulari, S., Dighe, H., Sharma, S., Gunjikar, R., Kumar, A., Kalele, K., Srinivas, V. K., Gangakhedkar, R. R., Ella, K. M., Abraham, P., Panda, S., & Bhargava, B.
Venue
Nature Communications
Published
2021-03-02
Volume
12
Issue
1
Pages
1386-1386
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3134470622
Cited by
107
References
16
FWCI
7.18
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. https://app.cochat.ai/papers/10.1038/s41467-021-21639-w
The paper
Yadav, P. D., Ella, R., Kumar, S., Patil, D. R., Mohandas, S., Shete, A. M., Vadrevu, K. M., Bhati, G., Sapkal, G., Kaushal, H., Patil, S., Jain, R., Deshpande, G., Gupta, N., Agarwal, K., Gokhale, M., Mathapati, B., Metkari, S., Mote, C., . . . Bhargava, B. (2021). Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nature Communications. https://doi.org/10.1038/s41467-021-21639-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.